Follow
Ted M. Lakowski
Ted M. Lakowski
Associate Professor and Director of the Pharmaceutical Analysis Laboratory, University of Manitoba
Verified email at ad.umanitoba.ca
Title
Cited by
Cited by
Year
Kinetic analysis of human protein arginine N-methyltransferase 2: formation of monomethyl-and asymmetric dimethyl-arginine residues on histone H4
TM Lakowski, A Frankel
Biochemical Journal 421 (2), 253-261, 2009
1472009
A kinetic study of human protein arginine N-methyltransferase 6 reveals a distributive mechanism
TM Lakowski, A Frankel
Journal of biological chemistry 283 (15), 10015-10025, 2008
1032008
Deep graph embedding for prioritizing synergistic anticancer drug combinations
P Jiang, S Huang, Z Fu, Z Sun, TM Lakowski, P Hu
Computational and structural biotechnology journal 18, 427-438, 2020
842020
Transcriptional regulation of brain-derived neurotrophic factor (BDNF) by methyl CpG binding protein 2 (MeCP2): a novel mechanism for re-myelination and/or myelin repair …
T KhorshidAhmad, C Acosta, C Cortes, TM Lakowski, S Gangadaran, ...
Molecular neurobiology 53, 1092-1107, 2016
812016
Physiologic changes in the heart following cessation of mechanical ventilation in a porcine model of donation after circulatory death: implications for cardiac transplantation
CW White, R Lillico, J Sandha, D Hasanally, F Wang, E Ambrose, A Müller, ...
American Journal of Transplantation 16 (3), 783-793, 2016
712016
A Protein Arginine N-Methyltransferase 1 (PRMT1) and 2 Heteromeric Interaction Increases PRMT1 Enzymatic Activity
ML Pak, TM Lakowski, D Thomas, MI Vhuiyan, K Hüsecken, A Frankel
Biochemistry 50 (38), 8226-8240, 2011
572011
Calcium‐induced folding of a fragment of calmodulin composed of EF‐hands 2 and 3
TM Lakowski, GM Lee, M Okon, RE Reid, LP McIntosh
Protein science 16 (6), 1119-1132, 2007
462007
Nη-Substituted Arginyl Peptide Inhibitors of Protein Arginine N-Methyltransferases
TM Lakowski, P ’t Hart, CA Ahern, NI Martin, A Frankel
ACS chemical biology 5 (11), 1053-1063, 2010
442010
SARS‐CoV‐2 multifaceted interaction with the human host. Part II: Innate immunity response, immunopathology, and epigenetics
TH Beacon, RC Su, TM Lakowski, GP Delcuve, JR Davie
IUBMB life 72 (11), 2331-2354, 2020
432020
PRMT2 interacts with splicing factors and regulates the alternative splicing of BCL-X
MI Vhuiyan, ML Pak, MA Park, D Thomas, TM Lakowski, CE Chalfant, ...
The journal of biochemistry 162 (1), 17-25, 2017
372017
Förster resonance energy transfer measurements of cofactor‐dependent effects on protein arginine N‐methyltransferase homodimerization
D Thomas, TM Lakowski, ML Pak, JJ Kim, A Frankel
Protein Science 19 (11), 2141-2151, 2010
342010
Approaches to measuring the activities of protein arginine N-methyltransferases
TM Lakowski, C Zurita-Lopez, SG Clarke, A Frankel
Analytical biochemistry 397 (1), 1, 2010
332010
HDAC inhibitors induce global changes in histone lysine and arginine methylation and alter expression of lysine demethylases
R Lillico, MG Sobral, N Stesco, TM Lakowski
Journal of proteomics 133, 125-133, 2016
312016
Selective DOT1L, LSD1, and HDAC class I inhibitors reduce HOXA9 expression in MLL-AF9 rearranged leukemia cells, but dysregulate the expression of many histone-modifying enzymes
R Lillico, CK Lawrence, TM Lakowski
Journal of proteome research 17 (8), 2657-2667, 2018
302018
Peptidic Partial Bisubstrates as Inhibitors of the Protein Arginine N‐Methyltransferases
P 't Hart, TM Lakowski, D Thomas, A Frankel, NI Martin
ChemBioChem 12 (9), 1427-1432, 2011
272011
Disposition, metabolism and histone deacetylase and acetyltransferase inhibition activity of tetrahydrocurcumin and other curcuminoids
JT Novaes, R Lillico, CL Sayre, K Nagabhushanam, M Majeed, Y Chen, ...
Pharmaceutics 9 (4), 45, 2017
262017
MS3 fragmentation patterns of monomethylarginine species and the quantification of all methylarginine species in yeast using MRM3
TM Lakowski, A Szeitz, ML Pak, D Thomas, MI Vhuiyan, J Kotthaus, ...
Journal of proteomics 80, 43-54, 2013
242013
Antimicrobial prophylaxis for patients undergoing cardiac surgery: intraoperative cefazolin concentrations and sternal wound infections
SA Zelenitsky, D Calic, RC Arora, HP Grocott, TM Lakowski, R Lillico, ...
Antimicrobial Agents and Chemotherapy 62 (11), 10.1128/aac. 01360-18, 2018
202018
Absolute oral bioavailability of creatine monohydrate in rats: debunking a myth
EA Alraddadi, R Lillico, JL Vennerstrom, TM Lakowski, DW Miller
Pharmaceutics 10 (1), 31, 2018
202018
Quantification of cefazolin in serum and adipose tissue by ultra high performance liquid chromatography-Tandem mass spectrometry (UHPLC–MS/MS): Application to a pilot study of …
R Lillico, CL Sayre, DS Sitar, NM Davies, CM Baron, TM Lakowski
Journal of Chromatography B 1031, 94-98, 2016
192016
The system can't perform the operation now. Try again later.
Articles 1–20